Your browser doesn't support javascript.
loading
Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study.
May, Margaret T; Vehreschild, Jorg-Janne; Trickey, Adam; Obel, Niels; Reiss, Peter; Bonnet, Fabrice; Mary-Krause, Murielle; Samji, Hasina; Cavassini, Matthias; Gill, Michael John; Shepherd, Leah C; Crane, Heidi M; d'Arminio Monforte, Antonella; Burkholder, Greer A; Johnson, Margaret M; Sobrino-Vegas, Paz; Domingo, Pere; Zangerle, Robert; Justice, Amy C; Sterling, Timothy R; Miró, José M; Sterne, Jonathan A C; Boulle, Andrew; Stephan, Christoph; Miro, Jose M; Cavassini, Matthias; Chêne, Geneviève; Costagliola, Dominique; Dabis, François; Monforte, Antonella D'Arminio; Del Amo, Julia; Van Sighem, Ard; Fätkenheuer, Gerd; Gill, John; Guest, Jodie; Haerry, David Hans-Ulrich; Hogg, Robert; Justice, Amy; Shepherd, Leah; Obel, Neils; Crane, Heidi; Smith, Colette; Reiss, Peter; Saag, Michael; Sterling, Tim; Teira, Ramon; Williams, Matthew; Zangerle, Robert; Sterne, Jonathan; May, Margaret.
Afiliação
  • May MT; Schoolof Social and Community Medicine, University of Bristol, United Kingdom.
  • Vehreschild JJ; Clinical Trials Unit II Infectious Diseases, University of Cologne, Germany.
  • Trickey A; Schoolof Social and Community Medicine, University of Bristol, United Kingdom.
  • Obel N; Department of Infectious Diseases, Copenhagen University Hospital, Denmark.
  • Reiss P; Department of Global Health, Academic Medical Center, University of Amsterdam, and Amsterdam Institute of Global Health and Development HIV Monitoring Foundation.
  • Bonnet F; Department of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity-Amsterdam, Academic Medical Center, The Netherlands.
  • Mary-Krause M; Bordeaux University, ISPED, INSERM U897.
  • Samji H; CHU de Bordeaux.
  • Cavassini M; Sorbonne Universités, UPMC Université Paris 06, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.
  • Gill MJ; Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.
  • Shepherd LC; Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Switzerland.
  • Crane HM; Division of Infectious Diseases, University of Calgary, Canada.
  • d'Arminio Monforte A; Research Department of Infection and Population Health, University College London Medical School, United Kingdom.
  • Burkholder GA; Center for AIDS Research, University of Washington, Seattle.
  • Johnson MM; Monforte Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy.
  • Sobrino-Vegas P; Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham.
  • Domingo P; Department of HIV Medicine, Royal Free London NHS Foundation Trust, United Kingdom.
  • Zangerle R; Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid.
  • Justice AC; Department of Medicine, Autonomous University of Barcelona, Spain.
  • Sterling TR; Medical University Innsbruck, Austria.
  • Miró JM; Yale University School of Medicine, New Haven.
  • Sterne JAC; Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut.
  • Boulle A; Hospital Clinic-IDIBAPS, University of Barcelona, Spain.
  • Stephan C; Schoolof Social and Community Medicine, University of Bristol, United Kingdom.
Clin Infect Dis ; 62(12): 1571-1577, 2016 06 15.
Article em En | MEDLINE | ID: mdl-27025828

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Contagem de Linfócito CD4 / Antirretrovirais Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Contagem de Linfócito CD4 / Antirretrovirais Idioma: En Ano de publicação: 2016 Tipo de documento: Article